Centre Francois Baclesse
Clinical trials sponsored by Centre Francois Baclesse, explained in plain language.
-
New combo offers hope for lung cancer patients resistant to targeted drugs
Disease control CompletedThis study tested a combination of chemotherapy (platinum and pemetrexed) plus an immunotherapy drug (atezolizumab), with or without another drug (bevacizumab), in 150 adults with advanced non-squamous lung cancer that has specific gene changes (EGFR, ALK, or ROS1) and has stoppe…
Phase: PHASE2 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated May 15, 2026 11:52 UTC
-
Immunotherapy plus chemo shows promise against stomach cancer
Disease control CompletedThis study tested whether adding the immunotherapy drug spartalizumab to standard chemotherapy (FLOT) helps people with stomach cancer that can be removed by surgery. 67 adults with early-stage stomach cancer received the drug combination before and after surgery. The main goal w…
Phase: PHASE2 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Targeted chemo shows promise for tough prostate cancer
Disease control CompletedThis study tested the chemotherapy drug carboplatin in 16 men with advanced prostate cancer that no longer responds to hormone therapy. The cancer had specific gene changes that might make it sensitive to this treatment. The goal was to see if carboplatin could shrink tumors or l…
Phase: PHASE2 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated May 08, 2026 12:04 UTC
-
VR headset calms nerves before thyroid surgery
Symptom relief CompletedThis study tested whether using a virtual reality headset with a relaxation app could lower anxiety in people about to have their thyroid removed. 82 adults took part. Researchers measured stress levels before and after the VR session. The goal was to see if this simple, drug-fre…
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated May 16, 2026 23:51 UTC
-
Hospital walking platform tested for older cancer patients
Symptom relief CompletedThis study looked at whether a special walking platform, designed to prevent falls and help with standing, could be used by elderly cancer patients (over 70) during their hospital stay. The goal was to see if patients would use it enough to make it worthwhile. The study included …
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC
-
Virtual reality boosts brain power for breast cancer survivors returning to work
Symptom relief CompletedThis study tested a virtual reality program to help breast cancer patients who have memory or concentration problems after treatment. 23 patients used the program for 10-15 minutes each week for 6 weeks. The goal was to see if patients would stick with the program and if it could…
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
App may cut hospital phone calls for cancer patients
Symptom relief CompletedThis study tested whether adding a telemonitoring app (Cureety) to standard care could reduce the number of phone calls hospital staff need to make to patients receiving injectable cancer treatments. The app collects blood test results and symptom reports to identify which patien…
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
Learning to beat cancer pain: education program shows promise
Symptom relief CompletedThis study tested whether a special education program could help cancer patients manage their pain better. 167 patients with cancer pain took part. The program taught them about pain, pain medicines, and how to talk to their doctors. The goal was to see if this learning reduced h…
Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated May 14, 2026 12:03 UTC
-
Ear acupuncture eases breast cancer drug pain in major trial
Symptom relief CompletedThis study tested whether auriculotherapy (a type of ear acupuncture) can reduce joint and muscle pain caused by aromatase inhibitors, a common hormone therapy for breast cancer. About 197 women with breast cancer who had pain from their medication were randomly assigned to recei…
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated May 05, 2026 11:56 UTC
-
Chemo's toll on daily life: study probes Long-Term effects in endometrial cancer patients
Knowledge-focused CompletedThis study looked at how chemotherapy affects the overall quality of life in women treated for stage II or III endometrial cancer. Researchers surveyed 51 women at least two years after their treatment ended, using standard questionnaires to measure physical, emotional, and socia…
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Knowledge-focused
Last updated May 16, 2026 23:38 UTC
-
Chemo nausea mystery: why do some patients still get sick despite treatment?
Knowledge-focused CompletedThis study looked at 300 adults receiving their first round of chemotherapy for cancer. Researchers wanted to understand why some patients still experience nausea and vomiting even when given standard anti-nausea medicines. Participants filled out a simple questionnaire to track …
Sponsor: Centre Francois Baclesse • Aim: Knowledge-focused
Last updated May 16, 2026 23:37 UTC